ASAPF (Aurora Spine) Debt-to-Asset : 0.31 (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Aurora Spine Debt-to-Asset?

Aurora Spine's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.29 Mil. Aurora Spine's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $3.42 Mil. Aurora Spine's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was $12.09 Mil. Aurora Spine's debt to asset for the quarter that ended in Sep. 2024 was 0.31.

Aurora Spine Debt-to-Asset Historical Data

The historical data trend for Aurora Spine's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Spine Debt-to-Asset Chart

Aurora Spine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.36

0.33

0.24

0.29

0.30

Aurora Spine Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.34	0.30	0.31	0.31	0.31

Competitive Comparison of Aurora Spine's Debt-to-Asset

For the Medical Devices subindustry, Aurora Spine's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aurora Spine's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Aurora Spine's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Aurora Spine Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Aurora Spine's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.231	+	3.415)	/	11.985
	=	0.30

Aurora Spine's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.285	+	3.416)	/	12.092
	=	0.31

Aurora Spine (OTCPK:ASAPF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Aurora Spine Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Aurora Spine's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurora Spine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aurora Spine Corp (OTCPK:ASAPF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

ASG:Canada

Address

20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1

Website

https://www.aurora-spine.com

Aurora Spine Corp is engaged in the business of the development and commercialization of minimally invasive interspinous fusion systems and devices. The product portfolio includes implants, surgical tools, and biologics. It derives revenues primarily from the sale of spinal surgery implants, consumable products used in spinal surgeries, and service revenue for referring products to its customers.